Akcea Therapeutics, Inc. Restricted Cash
Akcea Therapeutics, Inc. had Restricted Cash of $2.38 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2020-08-05
- 2020-06-30: Restricted Cash $2.38M.
- 2020-03-31: Restricted Cash $2.38M.
- 2019-12-31: Restricted Cash $2.38M.
- 2019-09-30: Restricted Cash $2.38M.
| Period end | Restricted Cash |
|---|---|
| 2020-06-30 | $2.38M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.38M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.38M 10-K · filed 2020-03-02 |
| 2019-09-30 | $2.38M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.38M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $2.38M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $2.38M 10-K · filed 2020-03-02 |
| 2018-09-30 | $2.38M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $2.38M 10-Q · filed 2019-08-07 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 |